Editorial

The importance of independent drug bulletins

Andrew Herxheimer
  • 1 February 2002
Editorial

Changes at Australian Prescriber

The Executive Editorial Board
  • 1 February 2002
Letters to the Editor

Evidence-based medicine

Ken Harvey, Peteris Darzins, Majella Pugh
  • 1 February 2002
Patient support organisations

Diabetes Australia

  • 1 February 2002
Book review

Drugs and Pregnancy

Jane Talbot
  • 1 February 2002
Article

Hypertension in diabetes

Julia Lowe
  • 1 February 2002
Article

Influenza immunisation

Robert Hall
  • 1 February 2002
Medicinal mishap

Serotonin syndrome

  • 1 February 2002
Article

I've missed a dose; what should I do?

Andrew Gilbert
  • 1 February 2002
Article

Clinical intuition: more than rational?

Glyn Brokensha
  • 1 February 2002
Article

Does pethidine still have a place in therapy?

Allan Molloy
  • 1 February 2002
NEW DRUGS
Darbepoetin alfa
  • 1 January 2002
Cefotaxime
  • 1 January 2002
Zoledronic acid
  • 1 January 2002
Laureth-9
  • 1 January 2002
Carvedilol
  • 1 January 2002
Follitropin beta
  • 1 January 2002
Rivastigmine
  • 1 January 2002
Flunitrazepam
  • 1 January 2002
Alprazolam
  • 1 January 2002
Oxcarbazepine
  • 1 January 2002
Sibutramine hydrochloride
  • 1 January 2002
Somatropin
  • 1 January 2002
Etanercept
  • 1 January 2002

IF YOU PRESCRIBE SUBSCRIBE

If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber

Subscribe